| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/30/1999 | CA2244435A1 New heterocyclic compounds, their preparation process and the pharmaceutical compounds containing them |
| 01/29/1999 | CA2243882A1 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors |
| 01/29/1999 | CA2211949A1 Nonaqueous compositions for parenteral administration |
| 01/28/1999 | WO1999004040A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
| 01/28/1999 | WO1999004011A2 Hiv-1 group o antigens and uses thereof |
| 01/28/1999 | WO1999003886A1 Tropoelastin derivatives |
| 01/28/1999 | WO1999003882A2 Human leukocyte calcium activated potassium channel polypeptide |
| 01/28/1999 | WO1999003878A2 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
| 01/28/1999 | WO1999003876A1 Steroid sulfatase inhibitors and methods for making and using the same |
| 01/28/1999 | WO1999003870A1 2-fluorofucosyl-n-aroylglucosamine derivatives, intermediates therefor, and processes for producing these |
| 01/28/1999 | WO1999003861A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 01/28/1999 | WO1999003859A1 Novel spiroazabicyclic heterocyclic compounds |
| 01/28/1999 | WO1999003857A1 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives |
| 01/28/1999 | WO1999003855A1 Piperazine derivatives |
| 01/28/1999 | WO1999003854A1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 01/28/1999 | WO1999003848A1 Thiazole derivatives, method for their production and use |
| 01/28/1999 | WO1999003844A1 Pyrazine derivatives, preparation and medicines containing them |
| 01/28/1999 | WO1999003843A1 Polyhydroxyalkylpyrazine derivatives, preparation and medicines containing them |
| 01/28/1999 | WO1999003842A1 Polyhydroxyalkylpyrazine derivatives, preparation and medicines containing them |
| 01/28/1999 | WO1999003841A1 Polyhydroxybutylpyrazines, their preparation and medicines containing them |
| 01/28/1999 | WO1999003840A1 Medicines containing polyhydroxyalkylpyrazine derivatives, novel polyhydroxyalkylpyrazine derivatives and their preparation |
| 01/28/1999 | WO1999003839A1 Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them |
| 01/28/1999 | WO1999003838A1 2-(1,2,3,4-tetrahydroxybutyl)pyrazine derivatives, preparation and medicines containing them |
| 01/28/1999 | WO1999003837A1 2-substituted imidazoles useful in the treatment of inflammatory diseases |
| 01/28/1999 | WO1999003831A1 3-benzoylindole derivatives and drugs containing the same |
| 01/28/1999 | WO1999003828A1 Dihomo-seco-cholestanes with two unsaturated bones in the side chain |
| 01/28/1999 | WO1999003826A2 Metalloproteinase inhibitors |
| 01/28/1999 | WO1999003823A2 Novel polyamine analogues as therapeutic and diagnostic agents |
| 01/28/1999 | WO1999003822A1 Bicyclic metabotropic glutamate receptor ligands |
| 01/28/1999 | WO1999003820A1 Tramadol, salts thereof and process for their preparation |
| 01/28/1999 | WO1999003817A2 Aliphatic propargylamines as cellular rescue agents |
| 01/28/1999 | WO1999003509A2 Pharmaceutical products containing triiodoaromats containing perfluoroalkyl groups, and the use thereof in the treatment of tumours and interventional radiology |
| 01/28/1999 | WO1999003506A1 Remedies for solid tumor containing wilms' tumor gene (wt1) expression inhibitors |
| 01/28/1999 | WO1999003504A1 Medicinal compositions for treating immunodeficiency diseases |
| 01/28/1999 | WO1999003503A1 The use of angiostatic steroids in photodynamic therapy |
| 01/28/1999 | WO1999003498A1 USE OF FVIIa OR FVIIai FOR THE TREATMENT OF ADVERSE CONDITIONS RELATED TO THE FVIIa MEDIATED INTRACELLULAR SIGNALLING PATHWAY |
| 01/28/1999 | WO1999003486A1 Antacid and papain combination |
| 01/28/1999 | WO1999003483A1 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 01/28/1999 | WO1999003481A1 Compositions for lubricating and separating tissues and biological membranes |
| 01/28/1999 | WO1999003480A1 Use of adenosine tri- or tetra-phosphates and their analogues for the treatment of cerebral infarction |
| 01/28/1999 | WO1999003479A1 Lipid-based immune modulator composition |
| 01/28/1999 | WO1999003478A1 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor |
| 01/28/1999 | WO1999003477A1 Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide |
| 01/28/1999 | WO1999003476A1 Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 01/28/1999 | WO1999003475A1 Use of compositions containing the combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine |
| 01/28/1999 | WO1999003473A1 Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches |
| 01/28/1999 | WO1999003472A1 Peripherally acting anti-pruritic opiates |
| 01/28/1999 | WO1999003471A1 Improved delivery of multiple doses of medications |
| 01/28/1999 | WO1999003470A1 Medicinal product and method for treatment and prevention of cognitive disorders |
| 01/28/1999 | WO1999003469A1 Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri) |
| 01/28/1999 | WO1999003468A1 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 01/28/1999 | WO1999003467A1 Pharmaceutical compositions and methods for treating compulsive disorders using pyrrolidine derivatives |
| 01/28/1999 | WO1999003466A1 Prophylactic or therapeutic agent for amnesia |
| 01/28/1999 | WO1999003464A1 Hydroxycitric acid compositions, pharmaceutical and dietary supplements and food products made therefrom, and methods for their use in reducing body weight |
| 01/28/1999 | WO1999003463A1 Genital lubricants with zinc to reduce irritation and allergic reactions |
| 01/28/1999 | WO1999003462A1 Modification of nitric oxide activity to treat fas-induced pathologies |
| 01/28/1999 | WO1999003461A1 Oily patches for external use containing diclofenac sodium |
| 01/28/1999 | WO1999003460A1 Amino acid derivatives useful to treat stroke |
| 01/28/1999 | WO1999003459A1 Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
| 01/28/1999 | WO1999003458A1 Treatment of attention deficit hyperactivity disorder and narcolepsy |
| 01/28/1999 | WO1999003457A1 Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith |
| 01/28/1999 | WO1999003456A2 Method for prophylaxis or treatment of bone density loss |
| 01/28/1999 | WO1999003455A1 Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith |
| 01/28/1999 | WO1999003453A1 Novel pharmaceutical formulation with controlled release of active substances |
| 01/28/1999 | WO1999003451A1 Pharmaceutical formulations for oral administration |
| 01/28/1999 | WO1999003446A2 Antimicrobial cosmetic compositions |
| 01/28/1999 | WO1999003365A1 Nutritional composition containing methionine |
| 01/28/1999 | WO1999003364A1 Nutritional composition for subjects under stress |
| 01/28/1999 | WO1999003347A1 Method for treating nicotine addiction |
| 01/28/1999 | WO1998049138A3 Vitamin d3 analogs with bis c-20 side chains |
| 01/28/1999 | WO1998046589A3 Indazole amide compounds as serotoninergic agents |
| 01/28/1999 | WO1998046576A3 Halo-alkoxycarbonyl prodrugs |
| 01/28/1999 | WO1998044913A3 Compositions containing mkc-442 in combination with other antiviral agents |
| 01/28/1999 | WO1998040056A3 Pyrrolidine and thiazole derivatives with metallo-beta-lactamase inhibitory properties |
| 01/28/1999 | WO1998038984A3 Formulations for hydrophobic pharmaceutical agents |
| 01/28/1999 | DE19732139A1 Immobilisierung von Vitamin-A-Säure durch kationische Polyelektrolyte Immobilization of vitamin A acid by cationic polyelectrolytes |
| 01/28/1999 | DE19732054A1 Preparation of a solidified medicament supply for use in inhalers |
| 01/28/1999 | DE19731571A1 Endothelin-Rezeptor-Antagonisten Endothelin receptor antagonists |
| 01/28/1999 | DE19731521A1 Budipin bei der Behandlung entzündlicher Erkrankungen des Nervensystems Budipine in the treatment of inflammatory diseases of the nervous system |
| 01/28/1999 | DE19731328A1 New 1-benzyl-imidazole and known tetrazole derivatives |
| 01/28/1999 | DE19731238A1 Verwendung von Aminoacridinen zur Behandlung solider Tumoren, Metastasen und Lymphomen Use of aminoacridines for the treatment of solid tumors, metastases and lymphomas |
| 01/28/1999 | CA2521392A1 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 01/28/1999 | CA2303833A1 Genital lubricants with zinc to reduce irritation and allergic reactions |
| 01/28/1999 | CA2297436A1 2-fluorofucosyl-n-aroylglucosamine derivatives, intermediates therefor, and processes for producing these |
| 01/28/1999 | CA2297413A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 01/28/1999 | CA2297133A1 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor |
| 01/28/1999 | CA2296687A1 Piperazine derivatives |
| 01/28/1999 | CA2296558A1 The use of angiostatic steroids in photodynamic therapy of ocular neovascularization |
| 01/28/1999 | CA2296540A1 Nutritional composition for subjects under stress |
| 01/28/1999 | CA2296503A1 Medicinal compositions for treating immunodeficiency diseases |
| 01/28/1999 | CA2296498A1 Steroid sulfatase inhibitors and methods for making and using the same |
| 01/28/1999 | CA2296468A1 Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri) |
| 01/28/1999 | CA2296442A1 Hiv-1 group o antigens and uses thereof |
| 01/28/1999 | CA2296310A1 Bicyclic metabotropic glutamate receptor ligands |
| 01/28/1999 | CA2296280A1 Compositions for lubricating and separating tissues and biological membranes |
| 01/28/1999 | CA2296145A1 Dihomo-seco-cholestanes with two unsaturated bonds in the side chain |
| 01/28/1999 | CA2295926A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
| 01/28/1999 | CA2295884A1 Tramadol, salts thereof and process for their preparation |
| 01/28/1999 | CA2295690A1 Lipid-based immune modulator composition |
| 01/28/1999 | CA2295021A1 2-substituted imidazoles useful in the treatment of inflammatory diseases |